PerkinElmer, Waltham, Mass, has announced the launch of two CE-marked chemiluminescent immunoassays for the detection of antibodies to Borrelia burgdorferi (Lyme disease) and Epstein-Barr virus (EBV/EBNA) on the Euroimmun RA 10 analyzer.
Used in conjunction with the chemiluminescent immunoassays, the Euroimmun analyzer functions as a compact automation solution in small- to medium-sized laboratories, or as a complement to high-throughput devices in large laboratories. Test- and lot-specific information, including stored standard curves, are imported into the analyzer’s database by means of a radio-frequency identification code, enabling error-free and convenient loading with efficient and secure test evaluation. The Euroimmun RA 10 analyzer allows continuous loading to enable processing of samples with minimal effort and short reaction times.
The new tests’ chemiluminescent immunoassay technology further minimizes reaction times, offering total analysis in 30 minutes or less. In addition, the preferred processing of emergency samples gives laboratories with different requirements and sample volumes flexibility in their routines.
“Lyme disease represents the most frequent tick-borne infection in the northern hemisphere, while EBV remains one of the most common human pathogens, with a prevalence of up to 99%,” says Wolfgang Schlumberger, PhD, CEO of Euroimmun. “Without treatment, Borrelia infections can lead to severe clinical symptoms. In case of EBV it is important to ensure early diagnosis due its high contagiousness. By introducing assays for the RA 10 analyzer, we’ve extended our already comprehensive portfolio of serological assays for Lyme disease and EBV diagnostics.”
For more information, visit Euroimmun.
Featured image: Microphotograph depicting leukemia cells containing Epstein-Barr virus (EBV), using a fluorescent antibody staining technique that causes the affected cells to glow green under ultraviolet light. EBV is a member of the Herpes virus family, and is one of the most common human viruses. Microphotograph by Paul M. Feorino, PhD, courtesy Centers for Disease Control and Prevention (ID 2984).